Philip Morris acquiring Cannabis inhaler developer for up to $650 million

The Israeli company’s main product is a metered-dose inhaler for pain reduction treatment using medical cannabis. Philip Morris, the international tobacco giant, is acquiring the Israeli company Syqe Medical in a deal that could reach $650 million, Calcalist has learned. Syqe’s main product is a